SCHEMBL1649890

SCHEMBL1649890

CCC(C(=O)O)(c1ccccc1)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 3/20 0.50
CYP2C9 P11712 3/20 0.49
ALDH1A1 P00352 3/20 0.48
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 2/20 0.47
HTT P42858 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PCSK7 Q16549 2/20 0.47
ABCB11 O95342 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
PDE4D Q08499 1/20 0.47
GPR35 Q9HC97 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103338 0.91 NQO1 (0.52) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL9286035 0.83 NQO1 (0.53) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL7351830 0.82 ALDH1A1 (0.50) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL9214360 0.79 NQO1 (0.52) NQO1CYP2C9ALDH1A1KDM4ELMNA
SCHEMBL7354341 0.78 KDM4E (0.55) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL3778823 0.76 ALDH1A1 (0.51) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL15514111 0.76 ALDH1A1 (0.51) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL12747979 0.74 KDM4E (0.62) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL12091846 0.72 CA12 (0.49) NQO1CYP2C9ALDH1A1CA12CA9
SCHEMBL2358729 0.72 LMNA (0.48) NQO1CYP2C9ALDH1A1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932405-B2 Halogenated ester derivatives of coumarins for the treatment of coagulation disorders ARYX THERAPEUTICS, INC. (US) 2011-04-26 US disclosed